Phenprocoumon
From Wikipedia, the free encyclopedia
Phenprocoumon
|
|
Systematic (IUPAC) name | |
2-hydroxy-3-(1-phenylpropyl)chromen-4-one | |
Identifiers | |
CAS number | |
ATC code | B01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C18H16O3 |
Mol. mass | 280.318 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 99% |
Metabolism | hepatic to inactive metabolites |
Half life | 5 to 6 days |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Phenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is an anticoagulant drug, a derivative of coumarin. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
[edit] External links
|
its new upgraded drug for anticoagulant properties and mechanism of action is unknown